The document defines a Pharmaceutical Quality System (PQS) and describes the PQS implemented at the Ninewells Aseptic Dispensing Unit. A PQS is the organized system that ensures medicinal products are of the required quality. The Ninewells unit prepares 38,000 items annually using isolators and laminar flow cabinets in grade B and C rooms. Key elements of its PQS include documentation control, standard operating procedures, change control, deviation management, personnel training, internal auditing, complaints handling, and quality reviews. However, a formal validation master plan is not currently in place.
Lean what 21 CFR Parts 210 and 211 are and how you an implement these regulations in your organization. For more information and tips on compliance go to http://compliance-insight.com/fda-gcp-and-gmp-training/21-cfr-210-211/
Complaints in Quality Management SystemMayuriMore15
Complaints evaluation and handling, Investigation and Determination, CAPA and Return and Recall of products in Quality Management system in pharmaceutical or any industry.
Quality Management system in accordance to Vol. 4 EU Guidelines for GMP for Medicinal Products for Human and Veterinary Use Chapter 1 Pharmaceutical QS
ICH Q10/ Q7.
ISO 9001/2015
Lean what 21 CFR Parts 210 and 211 are and how you an implement these regulations in your organization. For more information and tips on compliance go to http://compliance-insight.com/fda-gcp-and-gmp-training/21-cfr-210-211/
Complaints in Quality Management SystemMayuriMore15
Complaints evaluation and handling, Investigation and Determination, CAPA and Return and Recall of products in Quality Management system in pharmaceutical or any industry.
Quality Management system in accordance to Vol. 4 EU Guidelines for GMP for Medicinal Products for Human and Veterinary Use Chapter 1 Pharmaceutical QS
ICH Q10/ Q7.
ISO 9001/2015
Regulatory aspect of pharmaceutical change control systemDeveshDRA
CHANGE CONTROL,BENEFITS OF CHANGE CONTROL SYSTEM,MANAGEMENT OF CHANGE AND CONTINUOUS IMPROVEMENT(Prepare a Change Proposal,Classify & Approve Proposed Changes,Develop an Implementation Plan, Install the Change,Verify Installation,Close out the change
) FLOW CHART OF CHANGE MANAGEMENT,HANDLING AND CONTROLLING CHANGES,SOP ON CHANGE CONTROL SYSTEM,
CATEGORY OF CHANGES(Major Changes,Moderate changes,Minor changes),ENSURING TRAINING & PROCEDURES IN A MANAGEMENT OF CHANGE PROGRAM,LEVEL OF APPROVAL,REGULATOR PROSPECTIVE OF CHANGE CONTROL(21 CFR Part 211: Sec. 211.100,21 CFR Part 211.194 (Laboratory Records),ICH Q7A,USFDA Guidance for Industry: Change to an approved NDA or ANDA ( April 2004- Revison-1)),CONCLUSION
,
Bruno Flamion, Professor of Physiology and Pharmacology, Molecular Physiology Research Unit, University of Namur
Presentation at EIPG – VAPI-UPIP Symposium “Biotech and Advanced Therapies: Challenges and Opportunities” at the Faculty of Medicine and Pharmacy, Campus Jette, Vrije Universiteit van Brussel, Brussels 2013
Good Manufacturing Practice (GMP) | Arrelic InsightsArrelic
Good manufacturing practice (GMP) is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization. GMP is aimed primarily at diminishing the risks inherent in any pharmaceutical production, which may broadly be categorized in two groups: cross contamination/mix-ups and false labeling. Above all, manufacturers must not place patients at risk due to inadequate safety, quality or efficacy; for this reason, risk assessment has come to play an important role in WHO quality assurance guidelines.
This presentation contain introduction to Good Distribution Practices Guideline. and Legal GDP requirements put worldwide.
Good distribution practice (GDP) describes the minimum standards that a wholesale distributor must meet to ensure that the quality and integrity of medicines is maintained throughout the supply chain
Each participant in the distribution chain must agree by the relevant requirements in order to retain the original quality of pharmaceutical products.
Each activity in the distribution of pharmaceutical products shall be carried out according to the principles of Good Distribution Practices (GDP) as applicable.
The risks involved are likely to be of a nature comparable to those that are present in the industrial environment, such as mix-ups, adulteration, contamination, cross-contamination, and spurious.
The guideline addresses
Personnel
Quality System
Premises Warehousing and Storage
Documentation
Traceability
Complaints and Returns
Transportation
Regulatory aspect of pharmaceutical change control systemDeveshDRA
CHANGE CONTROL,BENEFITS OF CHANGE CONTROL SYSTEM,MANAGEMENT OF CHANGE AND CONTINUOUS IMPROVEMENT(Prepare a Change Proposal,Classify & Approve Proposed Changes,Develop an Implementation Plan, Install the Change,Verify Installation,Close out the change
) FLOW CHART OF CHANGE MANAGEMENT,HANDLING AND CONTROLLING CHANGES,SOP ON CHANGE CONTROL SYSTEM,
CATEGORY OF CHANGES(Major Changes,Moderate changes,Minor changes),ENSURING TRAINING & PROCEDURES IN A MANAGEMENT OF CHANGE PROGRAM,LEVEL OF APPROVAL,REGULATOR PROSPECTIVE OF CHANGE CONTROL(21 CFR Part 211: Sec. 211.100,21 CFR Part 211.194 (Laboratory Records),ICH Q7A,USFDA Guidance for Industry: Change to an approved NDA or ANDA ( April 2004- Revison-1)),CONCLUSION
,
Bruno Flamion, Professor of Physiology and Pharmacology, Molecular Physiology Research Unit, University of Namur
Presentation at EIPG – VAPI-UPIP Symposium “Biotech and Advanced Therapies: Challenges and Opportunities” at the Faculty of Medicine and Pharmacy, Campus Jette, Vrije Universiteit van Brussel, Brussels 2013
Good Manufacturing Practice (GMP) | Arrelic InsightsArrelic
Good manufacturing practice (GMP) is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization. GMP is aimed primarily at diminishing the risks inherent in any pharmaceutical production, which may broadly be categorized in two groups: cross contamination/mix-ups and false labeling. Above all, manufacturers must not place patients at risk due to inadequate safety, quality or efficacy; for this reason, risk assessment has come to play an important role in WHO quality assurance guidelines.
This presentation contain introduction to Good Distribution Practices Guideline. and Legal GDP requirements put worldwide.
Good distribution practice (GDP) describes the minimum standards that a wholesale distributor must meet to ensure that the quality and integrity of medicines is maintained throughout the supply chain
Each participant in the distribution chain must agree by the relevant requirements in order to retain the original quality of pharmaceutical products.
Each activity in the distribution of pharmaceutical products shall be carried out according to the principles of Good Distribution Practices (GDP) as applicable.
The risks involved are likely to be of a nature comparable to those that are present in the industrial environment, such as mix-ups, adulteration, contamination, cross-contamination, and spurious.
The guideline addresses
Personnel
Quality System
Premises Warehousing and Storage
Documentation
Traceability
Complaints and Returns
Transportation
Wondering what Scaled Agile is?
Hearing about SAFe but not sure how to apply it in your companies situation?
Come to our SAFe® in 8 Webinar on Thursday October 29, 2015!
We will discuss the shared understanding of the overarching approaches and principles at play in SAFe and understand how it allows large organizations to achieve enterprise agility.
Torrance real estate statistics and analysis for August 2015. Includes homes sales, listings and historical performance on a month to month and year over year basis.
As telcos go digital, cybersecurity risks intensify by pwcMert Akın
globalaviationairospace.com
Cyber security for telecommunications companies
The rewards and risks of the cloud, devices, and data
The fastest growing sources of security incidents, increase over 2013
Security strategies for evolving technologies
Strategic initiatives to improve cybersecurity
ICH Q10 GUIDELINES (PHARMACEUTICAL QUALITY SYSTEM)
- Contents
- ICH
- ICH GUIDELINES
- Objective
Q10 GUIDELINE
- Introduction
- Scope
- Objective of Q10 Guideline
- Elements
- CAPA System
- Change Management System
- Continual improvement of pharmaceutical quality system
- References
THANK YOU :)
Process validation.pptx_Process validation and inspection method with Exampl...ZerlealemTsegaye2
Process validation, definition and purpose
General principle
Traditional vs new paradigm
Risk assessment as part of process validation
Validation scheme: Monitoring and Sampling
Specific topics: Blend uniformity and validation of compression step
Process validation: other dosage forms
Process validation: sterile products
Process validation : Biological products
Retrospective validation
Summary: How to review protocol and report
List of References used
quality assurance, quality control, total quality management UNIT 1, b pharma 6th sem
Quality management in the drug industry
Why quality is important in pharmaceuticals?
Impacts of ignorance on quality
Quality control
Role of quality control in pharmaceutical industry
Objectives of quality control
Components of quality control
Functions of qc in pharmaceutical industry
Quality assurance
Total quality management
Characteristics of tqm
Benefits of tqm:
Total Quality Management (TQM) by Dr Anurag YadavDr Anurag Yadav
Laboratory Total Quality Management, Concept of Laboratory errors, the quality control material, quality assurance program, factors affecting the quality of report, Steps in quality management, PDCA cycle, accuracy, precision, EQAS, IQAS, Proficiency testing.
the details are related to medical laboratory and help MBBS, MD, BSc MLT, MSc MLT, etc
Food Quality Management System
(Production Planning and Control)
Food Quality
Need for Food Quality
GFSI
BRC
IFS
SQF 2000
HACCP
ISO 22000
Food Production
Production Planning
Quality management systems - INDUSTRIAL PHARMACY llJafarali Masi
syllabus
Quality management & Certifications: Concept of Quality, Total Quality Management, Quality by Design (QbD), Six Sigma concept, Out of Specifications (OOS), Change control, Introduction to ISO 9000 series of quality systems standards, ISO 14000, NABL, GLP
Quality management systems - INDUSTRIAL PHARMACY ll
PQS Presentation Final
1. Simbarashe Mavhunga
Senior Pharmacist Aseptic Dispensing Service
28th November 2016
AN ASEPTIC UNIT SHOULD HAVE A
COMPREHENSIVE AND CORRECTLY
IMPLEMENTED PHARMACEUTICAL
QUALITY SYSTEM (PQS)
Define what a PQS is and Describe the PQS in place at Ninewells Aseptic Dispensing Unit?
2. • Aseptic Processing
The manipulation of sterile starting materials and components in such a
way that they remain sterile and uncontaminated whilst being prepared for
presentation in a form suitable for administration to patients.
• Risk
The combination of the probability (likelihood) of occurrence of harm and
the severity (consequence) of that harm (based on ISO/IEC Guide 51) (ISO
2014). (ICH 2005).
• Risk Management
The systematic application of quality management policies, procedures, and
practices to the tasks of assessing, controlling, communicating and
reviewing risk. (ICH 2005)
• Quality
The totality of features and characteristics of a product or service that bears
its ability to satisfy stated or implied needs.
• Quality Assurance
The maintenance of a desired level of quality in a service or product,
especially by means of attention to every stage of the process of delivery or
production.
• Quality Management
The act of overseeing all activities and tasks needed to maintain a desired
level of excellence. This includes the determination of a quality policy,
creating and implementing quality planning and assurance, and quality
control and quality improvement.
• Pharmaceutical
A compound manufactured for use as a medicinal drug.
• System
A set of principles or procedures according to which something is done; an
organized scheme or method.
• Good Manufacturing Practice (GMP)
A system for ensuring that products are consistently produced and
controlled according to quality standards. It is designed to minimize the
risks involved in any pharmaceutical production that cannot be eliminated
through testing the final product.
Glossary/ Definition of Terms
3. Developments in EU Good Manufacturing Practice
(GMP) (EC 2015) have highlighted the need for a
robust Pharmaceutical Quality System (PQS) (ICH
2008). Anyone preparing medicines should
embrace the concept of Quality Management.
4. Pharmaceutical Quality System (PQS)
A wide-ranging concept, which covers all matters that individually
or collectively influence the quality of a product. Therefore PQS is
the sum total of the organised arrangements made with the
objective of ensuring that medicinal products are of the quality
required for their intended use.
5. • The design of the PQS should reflect the size and complexity of the preparation activities and should
incorporate risk management principles.
• The PQS should be fully documented, for example in a quality manual, and its effectiveness
monitored.
• The attainment of this quality objective is the responsibility of senior management and requires the
participation and commitment by staff in many different departments and at all levels to implement,
maintain and continually improve its effectiveness.
PQS Design and General Principles
7. Pharmaceutical Quality System Present in
the Ninewells Aseptic Dispensing Unit
• Approximately 38,000 aseptically dispensed items are prepared
annually within Aseptic Dispensing Unit.
• 15.3 WTE staff required to operate the service safely.
• Facilities
• 2 x 2 glove negative pressure isolator in grade B room (cytotoxic
preparation)
• 2 x Horizontal laminar flow cabinet in grade B room (PN preparation)
• 1 x 2 and 1 x 4 glove positive pressure isolator in grade C room
(CIVAS)
• 1 x 2 glove negative pressure isolator in grade C room (cytotoxic
preparation)
9. • Quality aspects throughout the product lifecycle.
Product Initiation – Risk Assessment done using tool developed by
ASSIG/SPQAG as detailed in National Standard Operating Procedures
(NSOPs). This takes into account the Capacity Plan.
• Documentation Control Systems
All aseptic documentation is written and approved, following the "Writing and
Approving Aseptic Documentation" National Standard Operating Procedure, by
Pharmacy staff authorised to write and approve documentation and who are familiar with
the processes involved.
• Standard Operating Procedures (SOPS)
The Aseptic Dispensing Unit uses a combination of NSOPs and Local work Instructions
in cases where there is a slight variation in practice from NSOPs. All SOPS are on
QPULSE.
Pharmaceutical Quality System Present in the
Ninewells Aseptic Dispensing Unit
10. • Change Control
A robust system for documenting and approving all planned changes (both temporary
or permanent) is present. All changes are evaluated for their potential impact on
product quality, and a decision made on whether or not to implement them.
• Deviation Management, planned and unplanned
Planned deviations are managed via change control procedures, while unplanned
deviations are investigated by completing a non conformance report whereby a root
cause analysis has been conducted. Corrective and /Preventative Action (CAPAs) are
identified in this process.
• Personnel and training policies
An approved and current training programme is available. Completion of training is
documented in individual training records for all staff. Directly Observed Procedures
method is used in the department and has proven effective.
Pharmaceutical Quality System Present in
the Ninewells Aseptic Dispensing Unit
11. • Internal audit
2 yearly audits are conducted as per comprehensive programme with Tayside
Pharmaceuticals Quality Assurance department.
• Complaints and Product Recall
Complaints are handled as per the NHS Tayside Local policy. A mechanism is in place
for recalls to Area Pharmacy Procurement Office (APPO). The Accountable Pharmacist or
the deputy shall discuss the appropriate action to be taken with the patient’s Clinical
Pharmacist.
• Validation Master Plan (VMP)
Currently there is no official VMP in the Ninewells Aspect Dispensing Unit. Due
to logistical issues with integrating the data. Validation Data is kept by the QA department at
Tayside Pharmaceuticals.
• Quality Review
No formal structures in place at the moment to conduct these reviews,
however there is a close working relation with the senior management and aseptic dispensing
services.
Pharmaceutical Quality System Present in
the Ninewells Aseptic Dispensing Unit
Are medicines different?
Potentially very hazardous to consumer
Consumed with trust
Very difficult to establish suitability by
testing alone
Safety & efficacy affected by formulation &
processing changes
It’s the right product
It’s the right strength
It’s free from contamination (impurities)
It’s not deteriorated
It’s in the right container (properly sealed and protected against
damage and contamination)
It’s correctly labelled
It’s properly sealed \ protected against contamination
adequate and appropriate resources (human, financial, materials, facilities and equipment)
5th Edition of Quality Assurance of Aseptic Preparation Services: Standards Beaney.
7680 aseptically dispensed CIVA
4300 aseptically dispensed PN products
22000 (13500 of which are pre-prepared products) aseptically dispensed cytotoxic
Senior management should determine and provide adequate and appropriate resources (human, financial, materials, facilities and equipment) to implement and maintain the PQS and continually improve its effectiveness. They should ensure that resources are appropriately applied to a specific product, process or site
COSHH- Control of Substances Hazardous to Health Regulations
Documentation Control:PHNA-D-SOP-2
Standard Template, Master Copies of all documentation is kept in the unit, Current version available with updated code, Documentation Register kept up to date, 2 yearly review ,Superseded clearly marked, Staff informed via change control
QPULSES currently Accountable can allocate and distribute the SOPS and they can control access to the SOPS. PHNA and PHTA- Change control, Environmental Monitoring, Product Preparation, Checking and Release. Worksheets standard template generated by chemocare, easycomp, datacomp.
Documenting and Approval: Deputy Accountable, Senior Pharmacy Technician, Accountable Pharmacist. National Template is used.
Change control: A formal system by which qualified representatives of appropriate disciplines review proposed or actual changes that might affect the validated status of facilities, systems, equipment or process. The intent is to determine the need for action that would ensure and document that the system is maintained in a validated state.
Implementation of all changes should be tracked and they should be reviewed after a suitable period to ascertain whether they have worked as intended and to establish whether they have had any unanticipated detrimental impact on product quality.
Effective training is a critical part of the quality assurance of aseptic products .
Senior Management are supportive and are aware of these audits and will assist in addressing some of the deficiencies identified in these audits.
LAERs
Complaints acknowledgement letter sent 3 days, response 20 days
VMP done as part of a PTQA project could not be commissioned due logistical issues, a fixed Aseptic Tech has taken on the project to see how the data sets and systems cab be integrated.
Quality Review, should be implemented as it now part of the new audit standards and is a project I am keen to work on.